Of all those progressing to insulin within 3 years of diagnosis, 47% (123/264) met the study criteria for type 1 diabetes and 18% (48/264) had intermediate C-peptide (≥200–<600 pmol/l). The gene discussed is INS; the disease is type 1 diabetes mellitus.